Targeting programmed death ligand 1 for anticancer therapy using computational drug repurposing and molecular simulations

Tallennettuna:

Bibliografiset tiedot
Julkaisussa:	Scientific Reports (Nature Publisher Group) vol. 15, no. 1 (2025), p. 28742-28754
Päätekijä:	Khan, Mohd Shahnawaz
Muut tekijät:	Shamsi, Anas, Shahwan, Moyad, Dinislam, Khuzin, Yadav, Dharmendra Kumar
Julkaistu:	Nature Publishing Group
Aiheet:	Food & Drug Administration > FDA Cancer PD-L1 protein Binders Bioinformatics Therapeutic targets Binding sites Biological products Drug development Computer applications Molecular dynamics Efficiency Proteins Simulation Principal components analysis FDA approval Immune checkpoint Antineoplastic drugs Pharmacokinetics Ligands Immunosuppressive agents Cancer therapies Environmental
Linkit:	Citation/Abstract Full Text Full Text - PDF
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!

Lisää ensimmäinen kommentti!